Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

NCT05715606 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Metabolically Armed CD19 CAR-T cells

Sponsor

Anhui Provincial Hospital

Collaborators

[object Object]